(Total Views: 291)
Posted On: 06/09/2021 4:58:52 PM
Post# of 44029

$BRAXF announced the publication of Implementation Guidance for the clinical use of rapid-acting Ketamine and Esketamine for treatment-resistant depression in the American Journal of Psychiatry.
https://theotcexchange.com/latest-news/the-ot...-guidance/
https://theotcexchange.com/latest-news/the-ot...-guidance/

